Bromide

Bromide

SCHEMBL8559533

Br.CCc1ccc(P)c(CCO)c1CC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5085462 0.84 GABRA1 (0.31) —
SCHEMBL6831030 0.82 GABRA1 (0.32) —
SCHEMBL12387626 0.80 GABRA1 (0.33) —
SCHEMBL12387633 0.80 GABRA1 (0.33) —
Iodide SCHEMBL5085340 0.80 GABRA1 (0.31) —
Hydrochloric Acid SCHEMBL2965190 0.80 GABRA1 (0.31) —
SCHEMBL14370241 0.73 PRKCI (0.33) —
SCHEMBL14993279 0.73 ALDH1A1 (0.33) —
SCHEMBL166573 0.72 GABRA1 (0.41) —
SCHEMBL29619533 0.72 GABRA1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5958906-A Phospholipid derivatives containing higher elements of the fifth main group ASTA-MEDICA AKTIENGESELLSCHAFT (DE) 1999-09-28 — — US disclosed
US-5637577-A TREATMENT OF POTOZOAL DISEASES ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1997-06-10 — — US disclosed
US-5449798-A Phospholipid derivatives containing higher elements of the fifth group ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1995-09-12 — — US disclosed
Send feedback